Development of ELISA and Rapid Testing Kits for COVID-19

The electronic data will consist of documenting the different diagnostic reagents imported, with their technical details, specifications and expiry dates. A record will be kept of the use of these reagents, and their performance characteristics in the research laboratory. The second main data set will involve the development of the diagnostic kits, and documentation of all physical, chemical and immunological parameters around each diagnostic procedure, and the outcomes, and whether success or failure. The third set of data will be generated when the developed diagnostic kits are tested against the known samples received from the commercial (Metropole) laboratories and the results compared.